Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Nausea and vomiting are the two most common side effects associated with cancer chemotherapy, and are referred to as chemotherapy induced nausea and vomiting (CINV).
This report elaborates on the current development of the CINV Existing and Pipeline Drugs industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Tesaro
Heron Therapeutics
Merck
GlaxoSmithKline
By Type:
Akynzeo (netupitant-palonosetron)
Kytril Generic (granisetron)
SUSTOL (extended release granisetron injection)
Rolapitant
Zofran Generic (ondansetron)
Emend (aprepitant)
Aloxi (palonosetron)
By Application:
Diagnostic Centers Therapeutics
Hospitals
Drugstores
Hospital Pharmacies
Specialty Clinics
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China CINV Existing and Pipeline Drugs Market Overview 2018-2029
-
1.1 China CINV Existing and Pipeline Drugs Industry Development Overview
-
1.2 China CINV Existing and Pipeline Drugs Industry Development History
-
1.3 China CINV Existing and Pipeline Drugs Industry Market Size (2018-2029)
-
1.4 China CINV Existing and Pipeline Drugs Market Analysis by Type from Production Side
-
1.4.1 China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of Akynzeo (netupitant-palonosetron) (2018-2029)
-
1.4.2 China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of Kytril Generic (granisetron) (2018-2029)
-
1.4.3 China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of SUSTOL (extended release granisetron injection) (2018-2029)
-
1.4.4 China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of Rolapitant (2018-2029)
-
1.4.5 China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of Zofran Generic (ondansetron) (2018-2029)
-
1.4.6 China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of Emend (aprepitant) (2018-2029)
-
1.4.7 China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of Aloxi (palonosetron) (2018-2029)
-
1.5 China CINV Existing and Pipeline Drugs Market Analysis by Application from Consumption End
-
1.5.1 China CINV Existing and Pipeline Drugs Sales Volume, Sales Value and Growth Rate of Diagnostic Centers Therapeutics (2018-2029)
-
1.5.2 China CINV Existing and Pipeline Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
1.5.3 China CINV Existing and Pipeline Drugs Sales Volume, Sales Value and Growth Rate of Drugstores (2018-2029)
-
1.5.4 China CINV Existing and Pipeline Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
1.5.5 China CINV Existing and Pipeline Drugs Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)
-
1.6 China CINV Existing and Pipeline Drugs Market Analysis by Region
-
1.6.1 North China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
1.6.3 South China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
1.6.4 East China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
Chapter 2 China CINV Existing and Pipeline Drugs Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on CINV Existing and Pipeline Drugs Market Status and Competition at home and abroad in 2023
-
2.2.2 China CINV Existing and Pipeline Drugs Market Status and Competition Analysis in 2023
-
2.2.3 China CINV Existing and Pipeline Drugs Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China CINV Existing and Pipeline Drugs Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on CINV Existing and Pipeline Drugs Industry Development
Chapter 3 CINV Existing and Pipeline DrugsIndustry Chain Analysis
-
3.1 CINV Existing and Pipeline Drugs Industry Chain
-
3.2 CINV Existing and Pipeline Drugs Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the CINV Existing and Pipeline Drugs Market
-
3.3 CINV Existing and Pipeline Drugs Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the CINV Existing and Pipeline Drugs Market
Chapter 4 China CINV Existing and Pipeline Drugs Market, by Type
-
4.1 China CINV Existing and Pipeline Drugs Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China CINV Existing and Pipeline Drugs Total Production Volume and Growth Rate from Production Side
-
4.5 China CINV Existing and Pipeline Drugs Production Volume and Growth Rate, by Type
-
4.5.1 China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of Akynzeo (netupitant-palonosetron)
-
4.5.2 China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of Kytril Generic (granisetron)
-
4.5.3 China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of SUSTOL (extended release granisetron injection)
-
4.5.4 China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of Rolapitant
-
4.5.5 China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of Zofran Generic (ondansetron)
-
4.5.6 China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of Emend (aprepitant)
-
4.5.7 China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of Aloxi (palonosetron)
Chapter 5 China CINV Existing and Pipeline Drugs Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China CINV Existing and Pipeline Drugs Total Market Size and Growth Rate from Consumption End
-
5.5 China CINV Existing and Pipeline Drugs Market Size and Growth Rate, by Application
-
5.5.1 China CINV Existing and Pipeline Drugs Market Size and Growth Rate of Diagnostic Centers Therapeutics
-
5.5.2 China CINV Existing and Pipeline Drugs Market Size and Growth Rate of Hospitals
-
5.5.3 China CINV Existing and Pipeline Drugs Market Size and Growth Rate of Drugstores
-
5.5.4 China CINV Existing and Pipeline Drugs Market Size and Growth Rate of Hospital Pharmacies
-
5.5.5 China CINV Existing and Pipeline Drugs Market Size and Growth Rate of Specialty Clinics
Chapter 6 China CINV Existing and Pipeline Drugs Market, by Region
-
6.1 China CINV Existing and Pipeline Drugs Production Volume and Production Value, by Region
-
6.2 China CINV Existing and Pipeline Drugs Sales Volume and Sales Value, by Region
Chapter 7 North China CINV Existing and Pipeline Drugs Market Analysis
-
7.1 North China CINV Existing and Pipeline Drugs Market, by Type
-
7.2 North China CINV Existing and Pipeline Drugs Market, by Application
Chapter 8 Central China CINV Existing and Pipeline Drugs Market Analysis
-
8.1 Central China CINV Existing and Pipeline Drugs Market, by Type
-
8.2 Central China CINV Existing and Pipeline Drugs Market, by Application
Chapter 9 South China CINV Existing and Pipeline Drugs Market Analysis
-
9.1 South China CINV Existing and Pipeline Drugs Market, by Type
-
9.2 South China CINV Existing and Pipeline Drugs Market, by Application
Chapter 10 East China CINV Existing and Pipeline Drugs Market Analysis
-
10.1 East China CINV Existing and Pipeline Drugs Market, by Type
-
10.2 East China CINV Existing and Pipeline Drugs Market, by Application
Chapter 11 Northeast China CINV Existing and Pipeline Drugs Market Analysis
-
11.1 Northeast China CINV Existing and Pipeline Drugs Market, by Type
-
11.2 Northeast China CINV Existing and Pipeline Drugs Market, by Application
Chapter 12 Southwest China CINV Existing and Pipeline Drugs Market Analysis
-
12.1 Southwest China CINV Existing and Pipeline Drugs Market, by Type
-
12.2 Southwest China CINV Existing and Pipeline Drugs Market, by Application
Chapter 13 Northwest China CINV Existing and Pipeline Drugs Market Analysis
-
13.1 Northwest China CINV Existing and Pipeline Drugs Market, by Type
-
13.2 Northwest China CINV Existing and Pipeline Drugs Market, by Application
Chapter 14 Company Profiles
-
14.1 Tesaro
-
14.1.1 Tesaro Company Profile
-
14.1.2 Tesaro CINV Existing and Pipeline Drugs Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Heron Therapeutics
-
14.2.1 Heron Therapeutics Company Profile
-
14.2.2 Heron Therapeutics CINV Existing and Pipeline Drugs Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Merck
-
14.3.1 Merck Company Profile
-
14.3.2 Merck CINV Existing and Pipeline Drugs Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Profile
-
14.4.2 GlaxoSmithKline CINV Existing and Pipeline Drugs Market Performance
-
14.4.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 CINV Existing and Pipeline Drugs Industry Research Conclusions
-
15.2 CINV Existing and Pipeline Drugs Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China CINV Existing and Pipeline Drugs Industry Market Size (2018-2029)
-
Figure China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of Akynzeo (netupitant-palonosetron) (2018-2029)
-
Figure China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of Kytril Generic (granisetron) (2018-2029)
-
Figure China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of SUSTOL (extended release granisetron injection) (2018-2029)
-
Figure China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of Rolapitant (2018-2029)
-
Figure China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of Zofran Generic (ondansetron) (2018-2029)
-
Figure China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of Emend (aprepitant) (2018-2029)
-
Figure China CINV Existing and Pipeline Drugs Production Volume, Production Value and Growth Rate of Aloxi (palonosetron) (2018-2029)
-
Figure China CINV Existing and Pipeline Drugs Sales Volume, Sales Value and Growth Rate of Diagnostic Centers Therapeutics (2018-2029)
-
Figure China CINV Existing and Pipeline Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)
-
Figure China CINV Existing and Pipeline Drugs Sales Volume, Sales Value and Growth Rate of Drugstores (2018-2029)
-
Figure China CINV Existing and Pipeline Drugs Sales Volume, Sales Value and Growth Rate of Hospital Pharmacies (2018-2029)
-
Figure China CINV Existing and Pipeline Drugs Sales Volume, Sales Value and Growth Rate of Specialty Clinics (2018-2029)
-
Figure North China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
Figure Central China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
Figure South China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
Figure East China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northeast China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
Figure Southwest China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
Figure Northwest China CINV Existing and Pipeline Drugs Market Size and Growth Rate from 2018-2029
-
Figure CINV Existing and Pipeline Drugs Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China CINV Existing and Pipeline Drugs Market Share by Type in 2018
-
Figure China CINV Existing and Pipeline Drugs Market Share by Type in 2023
-
Figure China CINV Existing and Pipeline Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of Akynzeo (netupitant-palonosetron) (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of Kytril Generic (granisetron) (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of SUSTOL (extended release granisetron injection) (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of Rolapitant (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of Zofran Generic (ondansetron) (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of Emend (aprepitant) (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Production Volume and Growth Rate of Aloxi (palonosetron) (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Market Share by Application in 2018
-
Figure China CINV Existing and Pipeline Drugs Market Share by Application in 2023
-
Figure China CINV Existing and Pipeline Drugs Total Market Size and Growth Rate from Consumption End
-
Figure China CINV Existing and Pipeline Drugs Market Size and Growth Rate of Diagnostic Centers Therapeutics (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Market Size and Growth Rate of Hospitals (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Market Size and Growth Rate of Drugstores (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Market Size and Growth Rate of Hospital Pharmacies (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Market Size and Growth Rate of Specialty Clinics (2018-2023)
-
Table China CINV Existing and Pipeline Drugs Production Volume by Region (2018-2023)
-
Table China CINV Existing and Pipeline Drugs Production Volume Share by Region (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Production Volume Share by Region (2018-2023)
-
Table China CINV Existing and Pipeline Drugs Production Value by Region (2018-2023)
-
Table China CINV Existing and Pipeline Drugs Production Value Share by Region (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Production Value Share by Region (2018-2023)
-
Table China CINV Existing and Pipeline Drugs Sales Volume by Region (2018-2023)
-
Table China CINV Existing and Pipeline Drugs Sales Volume Share by Region (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Sales Volume Share by Region (2018-2023)
-
Table China CINV Existing and Pipeline Drugs Sales Value by Region (2018-2023)
-
Table China CINV Existing and Pipeline Drugs Sales Value Share by Region (2018-2023)
-
Figure China CINV Existing and Pipeline Drugs Sales Value Share by Region (2018-2023)
-
Table North China CINV Existing and Pipeline Drugs Production Volume by Type (2018-2023)
-
Table North China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Figure North China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Table North China CINV Existing and Pipeline Drugs Sales Volume by Application (2018-2023)
-
Table North China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Figure North China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Table Central China CINV Existing and Pipeline Drugs Production Volume by Type (2018-2023)
-
Table Central China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Figure Central China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Table Central China CINV Existing and Pipeline Drugs Sales Volume by Application (2018-2023)
-
Table Central China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Figure Central China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Table South China CINV Existing and Pipeline Drugs Production Volume by Type (2018-2023)
-
Table South China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Figure South China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Table South China CINV Existing and Pipeline Drugs Sales Volume by Application (2018-2023)
-
Table South China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Figure South China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Table East China CINV Existing and Pipeline Drugs Production Volume by Type (2018-2023)
-
Table East China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Figure East China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Table East China CINV Existing and Pipeline Drugs Sales Volume by Application (2018-2023)
-
Table East China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Figure East China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Table Northeast China CINV Existing and Pipeline Drugs Production Volume by Type (2018-2023)
-
Table Northeast China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Figure Northeast China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Table Northeast China CINV Existing and Pipeline Drugs Sales Volume by Application (2018-2023)
-
Table Northeast China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northeast China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Table Southwest China CINV Existing and Pipeline Drugs Production Volume by Type (2018-2023)
-
Table Southwest China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Figure Southwest China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Table Southwest China CINV Existing and Pipeline Drugs Sales Volume by Application (2018-2023)
-
Table Southwest China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Figure Southwest China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Table Northwest China CINV Existing and Pipeline Drugs Production Volume by Type (2018-2023)
-
Table Northwest China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Figure Northwest China CINV Existing and Pipeline Drugs Production Volume Share by Type (2018-2023)
-
Table Northwest China CINV Existing and Pipeline Drugs Sales Volume by Application (2018-2023)
-
Table Northwest China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Figure Northwest China CINV Existing and Pipeline Drugs Sales Volume Share by Application (2018-2023)
-
Table Tesaro Company Profile
-
Table Tesaro CINV Existing and Pipeline Drugs Revenue, Price and Gross (2018-2023)
-
Table Heron Therapeutics Company Profile
-
Table Heron Therapeutics CINV Existing and Pipeline Drugs Revenue, Price and Gross (2018-2023)
-
Table Merck Company Profile
-
Table Merck CINV Existing and Pipeline Drugs Revenue, Price and Gross (2018-2023)
-
Table GlaxoSmithKline Company Profile
-
Table GlaxoSmithKline CINV Existing and Pipeline Drugs Revenue, Price and Gross (2018-2023)
-
